Biotechnology to identify lactose intolerance at its source
A fast and reliable genetic diagnostic solution to detect lactase deficiency and improve patient care.
Understanding our biotechnology: a diagnostic challenge
Lactose intolerance affects a significant portion of the global population, yet its diagnosis remains inconsistent and often inaccurate.
Current diagnostic methods rely on indirect testing, leading to variability in results and patient discomfort.
There is a clear need for a precise, reliable, and rapid genetic testing solution to identify lactase deficiency at its origin.
Biotechnology: a rapid genetic test for lactose intolerance
Eralydix develops a new biotechnology, an innovative genetic testing solution designed to accurately detect lactase deficiency through DNA analysis.
Our approach allows:
- fast and reliable diagnosis
- non-invasive testing
- improved patient management
This positions Eralydix as a key player in next-generation genetic diagnostics.
Advancing medical diagnostics through genetic innovation
Our solution brings strong value across multiple dimensions:
🧬 Medical value: more accurate diagnosis of lactose intolerance
🧪 Scientific relevance: leveraging genetic insights for better healthcare
🌍 Market potential: addressing a large and growing demand in diagnostic testing
Eralydix contributes to the evolution of personalized medicine.
Our biotechnology solution
Eralydix biotechnology is based on advanced genetic analysis, enabling rapid identification of lactase deficiency markers.
Our product is designed to be:
- scalable
- reliable
- compatible with modern diagnostic workflows
A better alternative to traditional diagnostic methods
Current diagnostic approaches include breath tests and empirical dietary trials, which can be unreliable or uncomfortable.
Eralydix differentiates itself by:
targeting the genetic origin of lactose intolerance
providing more accurate and consistent results
| What matters | Traditional tests | Eralydix test |
|---|---|---|
| Ease of use | ⚠️ Requires clinic visit or complex setup | ✅ Simple and easy to perform |
| Comfort | ⚠️ Can be uncomfortable or invasive | ✅ Non-invasive (simple cheek swab) |
| Accuracy | ⚠️ Results can vary depending on conditions | ✅ Consistent and reliable results |
| Speed | ⚠️ Can take time and multiple steps | ✅ Fast and efficient testing process |
| Scalability | ❌ Hard to deploy at large scale | ✅ Easily scalable for mass screening |
| Accessibility | ⚠️ Limited to specialized centers | ✅ Accessible in multiple settings worldwide |
| Cost | ⚠️ Moderate to high cost | ✅ Affordable solution |
investors & partnership with Eralydix
We are actively seeking strategic partners and investors to accelerate the development and deployment of our biotechnology.
Opportunities include: research collaborations, clinical partnerships and investment opportunities
A project driven by science and innovation
Eralydix is supported by a network of partners and experts in biotechnology and medical research.
Our team is dedicated to advancing genetic diagnostics and delivering impactful healthcare solutions. Experienced team with strong background in MedTech, law and strategic development.
Frank
Board advisory and strategy, Managing partner
BSc in radio physics /medical radiology
MBA
20 years in management position in pharma and MedTech in 4 different countries.
Key Focus on Strategy, Corporate Management, Governance
Elie
Board advisory and strategy, Managing partner
MLaw and Swiss qualified attorney at law
8 years experience in mergers & acquisitions and corporate matters, with particular focus on MedTech vertical
Key focus on investor relations, strategy and governance
Robert
Board advisory and strategy, Managing partner
He advises mid-size Canadian companies expanding into Europe on capital strategy and financial structuring.
A CPA (Canada) and CFA charter holder with 25+ years in European banking and asset management.
Our Eralydix solution biotechnology FAQ
🧬 What is Eralydix?
Eralydix is a start-up that is developing a rapid genetic testing solution to accurately identify the genetic cause of lactose intolerance.
🧪 How does your genetic test work?
Our approach is based on DNA analysis to detect lactase deficiency markers, enabling a precise and reliable diagnosis of lactose intolerance.
⚡ What makes your solution different from existing tests?
Unlike traditional diagnostic methods, our solution focuses on the genetic origin of lactose intolerance, providing faster, more accurate and non-invasive results.
🩺 What are the symptoms of lactose intolerance?
Symptoms vary from person to person and depending on age but generally involve stomach problems of varying severity. For more details and patient experiences, click on: “Individual cases” at the bottom of the page to view them.
🌍 Who can benefit from this biotechnology?
Our solution is designed for:
- healthcare professionals
- diagnostic laboratories
- research institutions
and ultimately benefits patients through improved diagnostic accuracy.
🤝 Are you looking for partners or investors?
Yes. We are actively seeking partners and investors to support the development and commercialization of our genetic testing solution.
📩 How can I get in touch?
You can contact us directly to learn more about our technology, partnership opportunities or project development.